Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 128,532 |
|
|||||
| News | - | ||||||
| Day High | 2.58 | Low High |
|||||
| Day Low | 2.32 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Galectin Therapeutics Inc | GALT | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.17 | -6.80% | 2.33 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.58 | 2.32 | 2.58 | 2.33 | 2.50 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,440 | 128,532 | US$ 2.49 | US$ 319,479 | - | 1.28 - 4.2684 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:48:17 | 10 | US$ 2.33 | USD |
Galectin Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 144.11M | 61.85M | - | 0 | -44.81M | -0.72 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Galectin Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GALT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.70 | 2.7997 | 2.32 | 2.63 | 125,713 | -0.37 | -13.70% |
| 1 Month | 3.18 | 3.28 | 2.32 | 2.76 | 115,156 | -0.85 | -26.73% |
| 3 Months | 2.36 | 4.2684 | 2.26 | 3.31 | 195,562 | -0.03 | -1.27% |
| 6 Months | 1.61 | 4.2684 | 1.555 | 2.89 | 129,448 | 0.72 | 44.72% |
| 1 Year | 1.41 | 4.2684 | 1.28 | 2.53 | 95,235 | 0.92 | 65.25% |
| 3 Years | 3.30 | 4.40 | 1.02 | 3.02 | 281,945 | -0.97 | -29.39% |
| 5 Years | 3.89 | 5.70 | 1.02 | 3.00 | 391,595 | -1.56 | -40.10% |
Galectin Therapeutics Description
| Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its lead galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis. |
